New Zealand markets close in 2 hours 13 minutes

Hyloris Pharmaceuticals SA (0AB6.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
11.70-1.08 (-8.47%)
At close: 05:10PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-15,762
-10,770
-11,579
-7,145
-5,373
Depreciation & amortisation
349
196
114
581
3,306
Stock-based compensation
539
560
576
485
0
Change in working capital
2,180
-3,375
-776
31
-2,089
Other working capital
-13,449
-13,893
-12,311
-5,193
-5,792
Other non-cash items
-491
695
197
1,477
-
Net cash provided by operating activities
-12,726
-13,154
-11,250
-4,570
-4,562
Cash flows from investing activities
Investments in property, plant and equipment
-723
-739
-1,061
-623
-1,230
Acquisitions, net
-
-
-1,270
0
0
Purchases of investments
0
-500
-1,178
-10
0
Sales/maturities of investments
-
-
216
0
3
Other investing activities
9,974
-
-1
-
-1
Net cash used for investing activities
9,654
-1,239
-3,075
-633
-1,228
Net change in cash
-3,261
-6,555
-14,387
64,194
-2,482
Cash at beginning of period
33,457
50,012
64,399
205
2,687
Cash at end of period
30,196
43,457
50,012
64,399
205
Free cash flow
Operating cash flow
-12,726
-13,154
-11,250
-4,570
-4,562
Capital expenditure
-723
-739
-1,061
-623
-1,230
Free cash flow
-13,449
-13,893
-12,311
-5,193
-5,792